Abstract: The present invention relates to a method for predicting a clinical response of a patient suffering from or at risk of developing gynecologic cancer towards a given mode of treatment, said method comprising the steps of: a) obtaining a biological sample from said patient; b) determining the expression level of at least one gene selected from the group comprising ALCAM, Osteopontin, Her-2/neu, EGFR, uPA/PAI-1 and/or ESR1, in particular of ALCAM and/or Osteopontin, in said sample; c) comparing the pattern of expression level (s) determined in (b) with one or several reference pattern (s) of expression levels; and d) predicting therapeutic success for said given mode of treatment in said patient or implementing therapeutic regimen in said patient from the outcome of the comparison in step (c).

Abstract: Antacids containing zeolitic sodium aluminosilicates and/or potassium aluminosilicates of the A, X, Y, or P type molecular sieves with pharmaceutical adjuvant material. Such antacids are useful in the treatment of gastric hyperacidity and other related conditions.

Abstract: Hollow, spherical bodies of solidified alkali metal silicates having the general formulaM.sub.2 O:x.SiO.sub.2where M is an alkali metal and x has a value greater than 3.6 and less than 12, said hollow bodies having an external diameter of from 1 to 5 mm, shell thickness of from 0.2 to 0.6 mm, a water content of from 10% to 30% by weight and a solids content of at least 70% by weight, the M.sub.2 O content of the shell of said hollow bodies being greater internally and less toward the exterior surface, as well as the process of producing said hollow, spherical bodies of solidified alkali metal silicate. The hollow spheres are expandable resulting in the formation of foam spheres having a loose surface. The hollow spheres are useful to give a uniform filling of narrow cavities and in the covering of liquids by floatable, optionally surface-active silicate-containing materials.